FZD7 and hepatocellular carcinoma: We have previously reported that the FZD7-mediated signalling was able to control the cancerous phenotype of human HCC cell lines through β-catenin protein regulation, and that one of the Wnt ligand candidate activators is WNT3 (Merle et al, 2004, 2005; Kim et al, 2008).